Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 15, Issue 4, 2008, Pages 417-422

  Uenishi, Takahiro ^a   Kubo, Shoji ^a   Yamazaki, Osamu ^b   Yamada, Terumasa ^c   Sasaki, Yo ^c   Nagano, Hiroaki ^d   Monden, Morito ^d  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA CITY GENERAL HOSPITAL   (Japan)

^c OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Intrahepatic cholangiocarcinoma; Intrahepatic metastases; Lymph node metastases; Postoperative outcome; Surgical indication

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER STAGING; CANCER SURVIVAL; DEMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LIVER RESECTION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT INDICATION;

AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES;

EID: 48749094198     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00534-007-1315-5     Document Type: Article

References (24)

1. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg 1990;211:277-287.
2. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Sixth report. Cancer 1987;60:1400-1411.
3. Uenishi T, Hirohashi K, Kubo S, Yamamoto T, Yamazaki O, Hirohashi K. Clinicopathological factors predicting outcome after resection of mass-forming intrahepatic cholangiocarcinoma. Br J Surg 2001;88:969-974.
4. Okabayashi T, Yamamoto J, Kosuge T, Shimada K, Yamasaki S, Takayama T, et al. A new staging system for mass-forming intrahepatic cholangiocarcinoma. Cancer 2001;92:2374-2383.
5. Inoue K, Makuuchi M, Takayama T, Torzilli G, Yamamoto J, Shimada K, et al. Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery 2000;127:498-505.
6. Kawarada Y, Yamagiwa K, Das BC. Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma. Am J Surg 2002;183:679-685.
7. Isa T, Kusano T, Shimoji H, Takashima Y, Muto Y, Furukawa M. Predictive factors for long-term survival in patients with intrahepatic cholangiocarcinoma. Am J Surg 2001;181:507-511.
8. Shimada M, Yamashita Y, Aishima S, Shirabe K, Takenaka K, Sugimachi K. Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg 2001;88:1463-1466.
9. Shirabe K, Shimada M, Harimoto N, Sugimachi K, Yamashita Y, Tsujita E, et al. Intrahepatic cholangiocarcinoma: Its mode of spreading and therapeutic modalities. Surgery 2002;131(1 Suppl):S159-164.
10. Nozaki Y, Yamamoto M, Ikai I, Yamamoto Y, Ozaki N, Fujii H, et al. Reconsideration of the lymph node metastasis pattern (N factor) from intrahepatic cholangiocarcinoma using the International Union Against Cancer TNM staging system for primary liver carcinoma. Cancer 1998;83:1923-1929.
11. Suzuki S, Sakaguchi T, Yokoi Y, Okamoto K, Kurachi K, Tsuchiya Y, et al. Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma. World J Surg 2002;26:687-693.
12. Uenishi T, Yamazaki O, Yamamoto T, Hirohashi K, Tanaka H, Tanaka S, et al. Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 2005;12:479-483.
13. Morimoto Y, Tanaka Y, Ito T, Nakahara M, Nakaba H, Nishida T, et al. Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 2003;10:432-440.
14. Nakagawa T, Kamiyama T, Kurauchi N, Matsushima M, Nakanishi K, Kamachi H, et al. Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma. World J Surg 2005;29:728-733.
15. Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, Yoshidome H, et al. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg 2002;89:1525-1531.
16. Tsuji T, Hiraoka T, Kanemitsu K, Takamori H, Tanabe D, Tashiro S. Lymphatic spreading pattern of intrahepatic cholangiocarcinoma. Surgery 2001;129:401-407.
17. Sobin L, Wittekind C. TNM Classification of malignant tumors. 5th ed. New York: Wiley-Liss; 1997.
18. The Japan Liver Cancer Study Group. Classification of primary liver cancer. 1st ed. Tokyo: Kanehara; 1997.
19. Terminology Committee of the IHPBA. Terminology of liver anatomy and resections. HPB 2000;2:333-339.
20. The Liver Cancer Study Group of Japan. General rules for the clinical and pathological study of primary liver cancer. 2nd ed. Tokyo: Kanehara; 2003.
21. Yamamoto M, Takasaki K, Imaizumi T, Ariizumi S, Matsumura N, Nakano M. A long-term survivor of intrahepatic cholangiocarcinoma with lymph node metastasis: A case report. Jpn J Clin Oncol 2002;32:206-209.
22. Murakami Y, Yokoyama T, Takesue Y, Hiyama E, Yokoyama Y, Kaneko T, et al. Long-term survival of peripheral intrahepatic cholangiocarcinoma with metastases to the para-aortic lymph nodes. Surgery 2000;127:105-106.
23. Asakura H, Ohtsuka M, Ito H, Kimura F, Ambiru S, Shimizu H, et al. Long-term survival after extended surgical resection of intrahepatic cholangiocarcinoma with extensive lymph node metastasis. Hepatogastroenterology 2005;52:722-724.
24. Uenishi T, Yamazaki O, Horii K, Yamamoto T, Kubo S. A long-term survivor of intrahepatic cholangiocarcinoma with paraaortic lymph node metastasis. J Gastroenterol 2006;41:391-392.